Tesofensine 250 mcg capsule

Tesofensine 250 mcg Capsule is an investigational oral compound studied for its effects on weight management, appetite suppression, and metabolic regulation. Tesofensine functions primarily as a triple monoamine reuptake inhibitor, blocking the reuptake of dopamine, serotonin, and norepinephrine, which enhances satiety, reduces caloric intake, and may increase energy expenditure. At a dose of 250 mcg (0.25 mg), this capsule represents a commonly studied low-to-moderate range used in clinical research evaluating safety and efficacy for obesity treatment. Tesofensine’s mechanism acts centrally within the brain, particularly in appetite-regulating pathways of the hypothalamus, leading to reduced hunger and improved control over food intake. Clinical studies have demonstrated that tesofensine can produce significant weight loss and fat reduction, with greater efficacy than some earlier anti-obesity agents, though its stimulant-like effects require monitoring: https://pubmed.ncbi.nlm.nih.gov/20300077/ Additional research highlights its action on monoamine transporters and metabolic outcomes: https://pubmed.ncbi.nlm.nih.gov/19751298/